295 related articles for article (PubMed ID: 34312162)
1. Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients.
Mulhern JG; Fadia A; Patel R; Ficociello LH; Willetts J; Dahne-Steuber IA; Pollan MC; Mullon C; DeLisi J; Johnson C; Mysayphonh C; Kossmann RJ; Anger MS; Hymes JL
Clin J Am Soc Nephrol; 2021 Nov; 16(11):1720-1722. PubMed ID: 34312162
[No Abstract] [Full Text] [Related]
2. Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer.
McKenzie DR; Muñoz-Ruiz M; Monin L; Alaguthurai T; Lechmere T; Abdul-Jawad S; Graham C; Pollock E; Graham R; Sychowska K; Seow J; Tremain C; Gousis C; Domingo-Vila C; Cooper J; Vidler J; Owczarczyk K; Swampillai A; Kristeleit H; Malim MH; Fields P; Patten PEM; Papa S; North BV; Tree T; Doores KJ; Hayday AC; Irshad S
Cancer Cell; 2021 Nov; 39(11):1445-1447. PubMed ID: 34678151
[No Abstract] [Full Text] [Related]
3. COVID-19 Vaccination Imperatives in People on Maintenance Dialysis: An International Perspective.
Blake PG; Hladunewich MA; Oliver MJ
Clin J Am Soc Nephrol; 2021 Nov; 16(11):1746-1748. PubMed ID: 34281983
[No Abstract] [Full Text] [Related]
4. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
Hsu CM; Weiner DE; Manley HJ; Aweh GN; Ladik V; Frament J; Miskulin D; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
Clin J Am Soc Nephrol; 2022 Mar; 17(3):403-413. PubMed ID: 35144972
[TBL] [Abstract][Full Text] [Related]
5. Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma.
Aleman A; Upadhyaya B; Tuballes K; Kappes K; Gleason CR; Beach K; Agte S; Srivastava K; ; Van Oekelen O; Barcessat V; Bhardwaj N; Kim-Schulze S; Gnjatic S; Brown B; Cordon-Cardo C; Krammer F; Merad M; Jagannath S; Wajnberg A; Simon V; Parekh S
Cancer Cell; 2021 Nov; 39(11):1442-1444. PubMed ID: 34706273
[No Abstract] [Full Text] [Related]
6. COVID-19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis.
Garcia P; Anand S; Han J; Montez-Rath ME; Sun S; Shang T; Parsonnet J; Chertow GM; Schiller B; Abra G
J Am Soc Nephrol; 2022 Jan; 33(1):33-37. PubMed ID: 34645698
[No Abstract] [Full Text] [Related]
7. Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients.
Boyarsky BJ; Chiang TP; Ou MT; Werbel WA; Massie AB; Segev DL; Garonzik-Wang JM
Transplantation; 2021 Aug; 105(8):e82-e83. PubMed ID: 34098566
[No Abstract] [Full Text] [Related]
8. T-cell and Antibody Response After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant Recipients.
Devresse A; Saad Albichr I; Georgery H; Yombi JC; De Greef J; Belkhir L; Mzougui S; Scohy A; Darius T; Buemi A; Goffin E; Kabamba B; Kanaan N
Transplantation; 2021 Oct; 105(10):e142-e143. PubMed ID: 34310103
[No Abstract] [Full Text] [Related]
9. Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients.
Harrington P; Doores KJ; Saha C; Saunders J; Child F; Dillon R; Saglam S; Raj K; McLornan D; Avenoso D; Kordasti S; O'Reilly A; Espehana A; Lechmere T; Khan H; Malim MH; Harrison C; Mehra V; de Lavallade H
Cancer Cell; 2021 Nov; 39(11):1448-1449. PubMed ID: 34717827
[No Abstract] [Full Text] [Related]
10. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial.
Wu S; Huang J; Zhang Z; Wu J; Zhang J; Hu H; Zhu T; Zhang J; Luo L; Fan P; Wang B; Chen C; Chen Y; Song X; Wang Y; Si W; Sun T; Wang X; Hou L; Chen W
Lancet Infect Dis; 2021 Dec; 21(12):1654-1664. PubMed ID: 34324836
[TBL] [Abstract][Full Text] [Related]
11. Impact of Kidney Transplantation on Humoral Immunity Against SARS-CoV-2: A Case Series From Belgium.
Fernandes G; Devresse A; Scohy A; Yombi JC; Belkhir L; De Greef J; De Meyer M; Mourad M; Darius T; Buemi A; Kabamba B; Goffin E; Kanaan N
Transplantation; 2021 Nov; 105(11):e257-e258. PubMed ID: 34347716
[No Abstract] [Full Text] [Related]
12. Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Patients on Hemodialysis.
Sibbel S; McKeon K; Luo J; Wendt K; Walker AG; Kelley T; Lazar R; Zywno ML; Connaire JJ; Tentori F; Young A; Brunelli SM
J Am Soc Nephrol; 2022 Jan; 33(1):49-57. PubMed ID: 34789546
[TBL] [Abstract][Full Text] [Related]
13. Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies.
Hod T; Ben-David A; Olmer L; Levy I; Ghinea R; Mor E; Lustig Y; Rahav G
Transplantation; 2021 Nov; 105(11):e234-e243. PubMed ID: 34310101
[TBL] [Abstract][Full Text] [Related]
14. The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.
Zitt E; Davidovic T; Schimpf J; Abbassi-Nik A; Mutschlechner B; Ulmer H; Benda MA; Sprenger-Mähr H; Winder T; Lhotta K
Front Immunol; 2021; 12():704773. PubMed ID: 34220867
[TBL] [Abstract][Full Text] [Related]
15. Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?
Terpos E; Trougakos IP; Karalis V; Ntanasis-Stathopoulos I; Sklirou AD; Bagratuni T; Papanagnou ED; Patseas D; Gumeni S; Malandrakis P; Korompoki E; Dimopoulos MA
Am J Hematol; 2021 Sep; 96(9):E321-E324. PubMed ID: 34028867
[No Abstract] [Full Text] [Related]
16. SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans.
Forgacs D; Jang H; Abreu RB; Hanley HB; Gattiker JL; Jefferson AM; Ross TM
Front Immunol; 2021; 12():728021. PubMed ID: 34646267
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
Front Immunol; 2021; 12():690698. PubMed ID: 34276681
[TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of mRNA-based BNT162b2 Vaccine versus Adenovirus Vector-Based Ad26.COV2.S Vaccine for the Prevention of COVID-19 among Dialysis Patients.
Brunelli SM; Sibbel S; Karpinski S; Marlowe G; Walker AG; Giullian J; Van Wyck D; Kelley T; Lazar R; Zywno ML; Connaire JJ; Young A; Tentori F
J Am Soc Nephrol; 2022 Apr; 33(4):688-697. PubMed ID: 35135894
[TBL] [Abstract][Full Text] [Related]
19. Humoral and Cellular Immune Response After a 3-Dose Heterologous SARS-CoV-2 Vaccination Using the mRNA-BNT162b2 and Viral Vector Ad26COVS1 Vaccine in Hemodialysis Patients.
Davidovic T; Schimpf J; Abbassi-Nik A; Stockinger R; Sprenger-Mähr H; Lhotta K; Zitt E
Front Immunol; 2022; 13():907615. PubMed ID: 35812459
[TBL] [Abstract][Full Text] [Related]
20. Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.
Danthu C; Hantz S; Dahlem A; Duval M; Ba B; Guibbert M; El Ouafi Z; Ponsard S; Berrahal I; Achard JM; Bocquentin F; Allot V; Rerolle JP; Alain S; Touré F
J Am Soc Nephrol; 2021 Sep; 32(9):2153-2158. PubMed ID: 34135083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
